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Abstract
The purpose of this investigation was to determine the ability of tetracycline-containing fibers to 
inhibit biofilm formation of peri-implantitis-associated pathogens [i.e., Porphyromonas gingivalis 
(Pg), Fusobacterium nucleatum (Fn), Prevotella intermedia (Pi), and Aggregatibacter 
actinomycetemcomitans (Aa)]. Tetracycline hydrochloride (TCH) was added to a poly(DL-lactide) 
[PLA], poly(ε-caprolactone) [PCL], and gelatin [GEL] polymer blend solution at distinct 
concentrations to obtain the following fibers: PLA:PCL/GEL (TCH-free, control), PLA:PCL/GEL
+5%TCH, PLA:PCL/GEL+10%TCH, and PLA:PCL/GEL+25%TCH. The inhibitory effect of 
TCH-containing fibers on biofilm formation was assessed by colony-forming units (CFU/mL). 
Qualitative analysis of biofilm inhibition was done via scanning electron microscopy (SEM). 
Statistical significance was reported at p<0.05. Complete inhibition of biofilm formation on the 
fibers was observed in groups containing TCH at 10 and 25 wt.%. Fibers containing TCH at 5 wt.
% demonstrated complete inhibition of Aa biofilm. Even though a marked reduction in CFU/mL 
was observed with an increase in TCH concentration, Pi proved to be the most resilient 
microorganism. SEM images revealed the absence of or a notable decrease in bacterial biofilm on 
the TCH-containing nanofibers. Collectively, our data suggests that tetracycline-containing fibers 
hold great potential as an antibacterial dental implant coating.
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Introduction
Osseointegrated titanium (Ti) implants have been used for decades and are considered a safe 
and predictable clinical therapy to replace missing teeth in partial and completely edentulous 
patients [1, 2]. Despite significant advances in implant surface science [3–5], particularly 
related to the positive role played by implant surface texture on bone integration [5, 6], the 
risk of infection and early implant failure still is a major clinical concern [7–11]. A recent 
meta-analysis indicates that there is some evidence of an increased number of implant 
failures and bone loss around implants (e.g., peri-implantitis) associated with periodontally-
compromised patients as compared to healthy individuals [11].
Peri-implantitis is defined as a progressive and irreversible polymicrobial infection and 
clinically characterized by soft tissue inflammation, bleeding and/or suppuration and rapid 
bone loss around dental implants [7, 8]. Subgingival anaerobic Gram-negative bacteria (e.g., 
Pi, Aa, and Pg), normally associated with periodontitis, are also related with peri-implantitis 
[7, 8]. Suffice it to say, once peri-implantitis is established, one needs to focus on 
decontamination of the implant surfaces, control of inflammation, inhibition of progressive 
bone loss, and potential regeneration of lost peri-implant bone. Over the years, besides the 
traditional non-surgical and surgical methods of treatment, novel and innovative 
therapeutics, for example those involving laser and photodynamic therapies have been tested 
with varying degrees of success [12, 13].
Remarkable progress in the field of nanotechnology has propelled materials research toward 
the development of bioactive antibacterial strategies [14, 18] that could be potentially used 
as a prophylactic approach to avoid early implant infection. Among a wide variety of 
therapeutic agents, tetracycline has been clinically used to disinfect contaminated implant 
surfaces [19, 20]. Tetracycline (TCH) is a protein synthesis inhibitor that binds to the 
bacterial 30S ribosome subunit and blocks the bond between tRNA and mRNA [21]. 
Notably, TCH has demonstrated its ability to not only function as an effective broad-
spectrum antibiotic against periodontitis and peri-implantitis-associated microbes (e.g., Pg, 
Fn, Pi, and Aa), but more importantly, it has been proven to increase fibroblastic cell 
proliferation [19] and inhibit collagenase activity [22]. Nonetheless, even though 
overwhelming amounts of research have been done to enhance/accelerate implant integration 
[3–6], very little work has been conducted to develop an antibacterial dental implant coating 
[23, 24].
In recent years, electrospinning, a nanotechnology-based technique, has been demonstrated 
to be an extremely feasible route to synthesize bioactive polymer nanofibers capable of 
sustained release of therapeutic antimicrobial drugs (e.g., metronidazole, ciprofloxacin, and 
minocycline, among others) [14–18]. Interestingly, hydroxyapatite-incorporated polymer 
nanofibers have been used to modify the surface of titanium implants, aiming to improve 
osseointegration [25]. Nonetheless, no single dental implant with antimicrobial surface 
properties is currently available. Therefore, there is a significant potential to develop an 
antibiotic-containing nanofiber-based polymer coating to minimize early implant loss, 
especially in periodontally-compromised patients. Thus, the present study aimed to 
synthesize tetracycline-containing fibers capable of inhibiting the growth of peri-implantitis-
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associated pathogens as the first step towards development of an antimicrobial dental 
implant coating.
Materials and methods
Materials
Four distinct peri-implantitis-associated Gram-negative anaerobic bacteria were selected for 
this study. Pg (ATCC 33277), Fn (ATCC 10953), Pi (ATCC 25611), and Aa (ATCC 33384) 
were procured from the American Type Culture Collection (ATCC, Manassas, VA, USA).
Poly(DL-lactide) (PLA, inherent viscosity: 0.55–0.75 dL/g in CHCl3) and poly(ε-
caprolactone) (PCL, inherent viscosity: 1.29 dL/g in CHCl3) were purchased from Lactel 
Absorbable Polymers (Durect Corporation, Birmingham, AL, USA). Type-B Gelatin (GEL) 
from bovine skin (bloom no. 225), tetracycline hydrochloride (TCH, molecular weight [Mw] 
480.90 g/mol), hexamethyldisilazane (HMDS), formaldehyde, and 1,1,1,3,3,3-hexafluoro-2-
propanol (HFP) were acquired from Sigma-Aldrich (Sigma-Aldrich Corporation, St. Louis, 
MO, USA). Brain heart infusion (BHI, Difco Laboratories Inc., Detroit, MI, USA) culture 
media containing 5 g/L yeast extract (BHI-YE, Difco Laboratories Inc., Detroit, MI, USA) 
with 5% v/v Vitamin K/hemin (Thermo Fisher Scientific, Inc., Pittsburgh, PA, USA) 
solution was used. Phosphate-buffered saline, ethanol, and blood agar plates supplemented 
with 5% sheep blood were obtained from Fisher Scientific Company LLC (Fair Lawn, NJ, 
USA).
Synthesis and Morphological Characterization of Tetracycline-containing Fibers
In this in vitro study, TCH-containing polymer fibers were synthesized via electrospinning 
using a laboratory-based system [14–18]. A syringe pump (Legato 200 KD Scientific Inc., 
Holliston, MA, USA), a high-voltage source (ES50P-10W/DAM, Gamma High-Voltage 
Research, Inc., Ormond Beach, FL, USA), and a grounded stainless steel collecting drum (ϕ 
= 4 cm) connected to a high-speed mechanical stirrer (BDC6015 Caframo, Wiarton, ON, 
CA) were used to process defect-free (i.e., bead-free) fibers. PLA, PCL, and GEL were 
dissolved in HFP (mass ratio of 2:2:1) overnight and under vigorous stirring to obtain a 75 
mg/mL blended polymer solution. Subsequently, TCH was individually incorporated at 
distinct concentrations (5, 10, and 25 wt.%, respective to the total polymer blend weight, i.e., 
450 mg in 6 mL of HFP) and stirred for 24 h before being electrospun into fibers. One 
control (TCH-free) and three experimental (TCH-containing) fiber groups were spun. The 
pure polymer blend (PLA:PCL/GEL) or the TCH-containing polymer solutions were 
individually loaded into plastic syringes (Becton-Dickinson, Franklin Lakes, NJ, USA) fitted 
with a metallic blunt end 27G needle. The polymer mixtures (4 mL) were then processed 
under optimized conditions (i.e., 1 mL/hr, 18-cm distance, and 18–22 kV) on an aluminum 
foil-covered rotating (120 rpm) mandrel at room temperature (RT). The electrospun fibers 
were placed in a desiccator for 24 h to ensure complete elimination of any remaining 
solvents. The electrospun fibers were morphologically characterized via scanning electron 
microscopy (SEM, JSM-5310LV, JEOL, Tokyo, Japan). The average fiber diameter was 
calculated from three distinct SEM images by measuring the diameter of 40 fibers per image 
(n=120 fibers/group) using a dedicated software (ImageJ 1.44i, National Institutes of Health, 
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Bethesda, MD, USA) [14–18]. High-performance liquid chromatography (HPLC) was used 
to evaluate TCH release profile from antibiotic-incorporated nanofibers [14]. In brief, TCH-
containing electrospun samples (15 × 15 mm2, n=4/group) were weighed and incubated in 
10 mL of PBS at 37°C. 1 mL aliquots were retrieved at different time intervals and 
replenished with equivalent amounts of fresh PBS. The TCH content (absorption peak 276.8 
nm) was determined using HPLC equipped with a UV-Vis detector (Perkin-Elmer, Shelton, 
CT, USA). TCH solutions at known concentrations were used to obtain the calibration 
curves [14].
Biofilm Inhibition Assay
The inhibitory effects of TCH-containing fibers on the biofilm growth of four 
periimplantitis-associated pathogens, i.e., Pg, Fn, Pi, and Aa, were evaluated using a 
previously well-characterized biofilm inhibition assay [16–18]. Electrospun samples (n=10/
group/bacteria) were cut (15 × 15 mm2) from the synthesized fibrous mats, mounted in a 
plastic cell culture device (CellCrown™, Scaffdex, Tampere, Finland), and placed in 24-well 
plates [18]. The samples tested included the three TCH-containing experimental groups (i.e., 
PLA:PCL/GEL+5wt.%TCH, PLA:PCL/GEL+10wt.%TCH, PLA:PCL/GEL+25wt.%TCH), 
and the control (i.e., pure PLA:PCL/GEL). Electrospun samples were disinfected with 2 mL 
of 70% ethanol for 30 min and rinsed (2×) with 2 mL of sterile 0.9% saline. All bacteria 
were cultured at 37°C for 48 h in 5 mL of BHI-YE in an anaerobic GasPak jar [18]. 50-μL 
of the 48 h bacterial suspensions (ca. 106 bacteria) was inoculated into each well with 2 mL 
of the growth media. Following the incubation period, the electrospun samples were 
removed from the wells using sterile forceps, washed gently (2×) with 1 mL of 0.9% saline 
and suspended in 2 mL of 0.9% saline, followed by sonication (10 s) and vortexing (30 s) 
[18]. The dislodged biofilm bacteria were plated onto anaerobic blood agar plates using a 
conventional spiral plater system [18]. For each sample, two dilutions were plated, one 
undiluted and one diluted (1:100). The plates were incubated under anaerobic conditions for 
48 h prior to evaluation using an automated colony counter (Synbiosis Design/Build, LLC, 
Frederick, MD, USA) to determine the colony-forming units (CFU/mL) to be compared 
with the data obtained from the TCH-free fibers [18]. Bacterial growth inhibition of the 
TCH-containing fibers and the control was qualitatively assessed using a scanning electron 
microscope (SEM). In brief, two additional samples per group were tested under the same 
protocol. After incubation, the samples were harvested, washed with PBS to remove 
unbound bacteria, and fixed in buffered 4% formaldehyde. After dehydration, using 
ascending ethanol gradients, and soaking in ethanol/hexamethyldisilazane gradients, samples 
were mounted on Al stubs, sputter-coated with gold and imaged using SEM [18].
Statistical analyses
Results are shown as the mean value plus or minus the standard deviation (±SD) of the 
mean. One-way ANOVA, followed by Tukey’s multiple comparisons, were used to evaluate 
the groups for differences in fiber diameter. A comparison between the groups for 
differences in bacterial counts was made using the Wilcoxon Rank Sum tests. A 5% 
significance level was used.
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Results
A representative SEM image of the 25 wt.% TCH-containing nanofibers is shown in Fig. 
1A; all groups demonstrated similar fiber morphology, regardless of the presence and 
concentration of TCH. Overall, regardless of the presence of TCH, a three-dimensional 
nanofibrous network with micron-sized pores was seen. The mean fiber diameter for all 
fibers ranged from 172 to 393 nm (Fig. 1B). The greatest mean fiber diameter was found in 
the 25 wt.%TCH-containing group (324±69 nm), followed in descending order by 10 wt.
%TCH (249±72 nm), 5 wt.%TCH (244±66 nm), and the control (221±49 nm). Regarding 
the mean drug release ability of the TCH-containing fibers, the greater the TCH content, the 
more TCH was released (Fig. 2A). All experimental groups displayed a burst release of 
TCH.
Pure PLA:PCL/GEL (TCH-free, control group) allowed significant biofilm formation as 
demonstrated by high colony-forming units (log10 CFU/mL) values (Fig. 2B) for all bacteria 
(Pi = 5.4; Pg = 5.6; Aa = 5.1; Fn = 3.7). Meanwhile, all TCH-containing fibers displayed 
antibacterial effects when compared to the control (Fig. 2B). All TCH-containing fibers 
significantly inhibited the growth of Aa. The control fibers had significantly (p=0.0001) 
higher bacteria counts than 5, 10, and 25 wt.%TCH. However, 5 wt.% was not significantly 
different from 10 or 25 wt.% (p>0.05). For Fn, the control group had a significantly higher 
count than the experimental groups. Worth mentioning, significant differences (p≤0.0002) in 
biofilm reduction were seen as a function of the TCH content, where increasing the TCH 
amount led to higher biofilm reduction. In the case of Pg, the control group had a 
significantly higher count than 5, 10, and 25 wt.%. Similar to Fn, 5 wt.%TCH had 
significantly (p≤0.0208) higher counts than 10 and 25 wt.%; however, 10 and 25 wt.% were 
not statistically different (p>0.05). Lastly, for Pi, the control group had a significantly 
(p=0.0002) higher count than 5, 10, and 25 wt.%. TCH incorporation at 25 wt.% had 
significantly lower counts than 5 wt.%TCH (p=0.0002) and 10 wt.%TCH (p=0.0017). No 
statistically significant difference (p=0.91) was seen between 5 and 10 wt.%TCH for Pi. 
Taken together, Pi biofilm demonstrated being the most resilient; however, there was a 
marked reduction in CFU/mL, with an increase in TCH concentration.
SEM imaging was carried out as a qualitative method to confirm the presence/absence of 
bacterial biofilm. SEM images obtained after biofilm exposure clearly demonstrated large 
and dense clusters for all examined bacteria (Pg, Fn, Pi, and Aa) throughout the TCH-free 
(control) electrospun fibers (Figs. 3A, 4A, 5A, and 6A). All the experimental groups 
exhibited an absence or a notable decrease in bacteria biofilm. Electrospun fibers containing 
TCH at 10 and 25 wt.% revealed complete elimination of Pg and Fn biofilms on the fibers 
(Figs. 3 and 4); however, few bacteria were observed on the surface of the 5 wt.% fibers 
(Figs. 3B and 4B). It is interesting to note that the characteristic morphology (i.e., spindle-
shaped) of Fn bacteria was clearly identified within the control group. Fig. 4A shows a 
representative SEM image, in which 30 measurements were taken of the diameter of the 
spindle-shaped bacteria. The mean Fn diameter was 487±159 nm, more than two-fold 
greater than the diameter of the TCH-free polymer fibers (221±49 nm). No evidence of Aa 
bacteria biofilm was found on the surfaces of any TCH-containing fibers. A notable decrease 
of Pi bacteria biofilm was seen as the concentration of TCH increased (Fig. 6).
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Discussion
In the past few years, the application of electrospun fibers as a delivery system of distinct 
drugs to aid an antibacterial property to metallic orthopedic implants has gained increased 
attention [23, 24]. Nevertheless, and to the best of our knowledge, TCH has so far never 
been considered in the fabrication of an alternative antimicrobial nanofibrous-based 
biodegradable dental implant coating. Taking into consideration that TCH is a broad-
spectrum antibiotic with well-known activity against periodontitis- and peri-implantitis-
associated microbes, the present study carries a strong clinical relevance in implant dentistry.
This in vitro study investigated the ability of TCH-containing polymer nanofibers to inhibit 
the growth of peri-implantitis-associated bacteria. Overall, the TCH-containing fibers 
exhibited a homogeneous architecture and satisfactory morphology (Fig. 1A). Hence, there 
were no clear differences between the TCH-containing and control (TCH-free) fibers, except 
for a slight increase in fiber diameter noted for the highest concentrated group (25 wt.
%TCH, Fig. 1B). At the moment, it can be speculated that the presence of hydroxyl groups 
in the molecular structure of TCH increased the viscosity of the polymer solution due to the 
increase in intermolecular (e.g., hydrogen bonding) interactions [26], which has probably 
affected the chain entanglement process during electrospinning, resulting in thicker fibers. 
Despite the absence of morphological differences between the synthesized fibers, all TCH-
containing fibers were able to inhibit or dramatically reduce biofilm growth (Fig. 2B) when 
compared to the control, which displayed the highest counts of viable cells on biofilms, thus 
supporting the potential use of these bioactive fibers as surface coating for titanium dental 
and orthopedic implants.
It is well-established in the literature that the presence of biofilm surrounding implant sites is 
a common reason, but not the only one, for early implant loss or peri-implantitis, especially 
in periodontally-compromised high-risk individuals [11]. Knowing that dental implants lack 
antibacterial properties and considering that they have an intrinsically rough and irregular 
surface topography, biofilm elimination is a very difficult task. According to the findings of 
the present study, modification of the titanium implants’ surface with TCH-containing 
polymer nanofibers holds great promise toward combating/controlling the accumulation of 
biofilm. Herein, both the TCH concentration and bacterial species tested significantly 
influenced the anti-biofilm effect. Overall, the most concentrated fibers (25 wt.%TCH) 
resulted in higher biofilm inhibition on the fibers, as compared to the less concentrated fibers 
(5 wt.%TCH), probably due to the release of greater amounts of the drug in the former 
group than in the latter (Fig. 2A) [16, 17]; the only exception was observed against Aa, in 
which all the TCH-containing fibers were able to completely inhibit biofilm growth, 
regardless of the TCH concentration (Fig. 2B). The higher susceptibility of Aa, even at low 
TCH concentration, can be explained by the low minimal inhibitory concentration (MIC) of 
tetracycline-based compounds against this bacterium, as suggested by a previous study [27]. 
Conversely, Pi demonstrated the lowest susceptibility to TCH, since even the 25 wt.%TCH 
group did not promote complete biofilm elimination. In this case, it is important to note that 
Pi has been reported to encode different copies of beta-lactamases and multidrug/efflux 
transporters, which provide resistance to antibiotics [28]. Furthermore, it can be speculated 
that the MIC of TCH would be greater against Pi compared to the other species. This has 
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been demonstrated by van Winkelhoff et al. [29] who reported that the MIC of tetracycline 
against Pi, Fn, Aa, and Pg was 2.0, 0.5, 0.19 and 0.023 mg/L, respectively. Consequently, Pi 
seems to be a more challenging pathogen to eliminate.
Another interesting finding of the present study is that increasing the concentration of TCH 
from 10 to 25 wt.% did not result in any positive (dose-dependent) effect in biofilm 
inhibition against the more susceptible bacteria species tested (i.e., Pg, Aa, and Fn) (Fig. 
2B). This is important to know, because the greater the content of TCH used, the greater the 
probability of increasing cytotoxic effects and bacterial resistance. According to the present 
results, the amount of TCH used for the preparation of the 10 wt.%TCH fibers was 
approximately 45 mg. However, it is worth mentioning that the real amount of TCH added 
into each fiber is much lower than this, since 45 mg was the total amount of the drug added 
into 6 mL of the polymer solution, which resulted in hundreds of thousands of fibers (Fig. 
1). In light of this, it can be inferred that even very low amounts of TCH are able to reduce 
susceptible bacteria, such as Pg, Aa, and Fn. Once again, the same pattern could not be 
extrapolated to the less susceptible bacteria tested (i.e., Pi), which, even after contact with 
the most concentrated (25 wt.%) fibers, biofilm was not completely eliminated. In fact, this 
may corroborate with recent literature that indicated Pi is one of the most common 
pathogens found in peri-implantitis [30, 31].
Taken together, successful TCH release from the electrospun polymer fibers was confirmed 
both by the HPLC data and, more importantly, by the significant reduction in bacterial 
biofilm. It is well-known that TCH acts inhibiting bacterial protein synthesis by preventing 
the association of aminoacyl-tRNA with the bacterial ribosome. Moreover, a recent study 
highlighted the antimicrobial action of TCH due to its ability to bind to various bacterial 
RNAs in alternative binding modes or sites, consequently disorganizing the biofilm structure 
[32].
SEM analysis of the fibers after the biofilm assay corroborates with the CFU/mL data, 
which indicates the presence of bacterial structures with different shapes/sizes (depending 
on the bacterial species) compared to the fibers could be easily observed on the TCH-free 
fibers (control). On the other hand, the presence of some bacteria could not be easily 
detected on the surface of the TCH-incorporated fibers, thus confirming the inhibitory 
effects. Only for the Pi group was the presence of some bacterial cells detected, even around 
the TCH-containing fibers, since the biofilm was not completely eliminated within this 
group (Fig. 6).
Conclusion
Our ongoing research focuses on synthesizing antibiotic-containing nanofibers on titanium 
dental implants [33] to first study in vitro the antimicrobial properties against a multispecies 
peri-implantitis-relevant biofilm, and later to evaluate its effects on a pre-clinical animal 
model. Taken together, this study demonstrated that antibiotic-containing fibers can 
effectively inhibit peri-implantitis-related biofilm formation, suggesting that tetracycline 
fibers hold great potential as an antibacterial implant coating.
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Fig. 1. 
(A) Representative SEM image of the PLA:PCL/GEL+25wt.%TCH fibers. Note the three-
dimensional nanofibrous network with micron-sized pores. (B) Mean fiber diameter 
(±standard deviation) for all electrospun fibers. Similar lowercase letters above bars indicate 
no significant differences at the P 0.05 level.
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Fig. 2. 
(A) Mean drug release profile of the TCH-containing groups. (B) Mean counts (expressed as 
log10 CFU/mL) of viable biofilm cells cultured on electrospun fibers. Distinct lowercase 
letters above standard deviation (SD) bars indicate statistically significant differences among 
fibers for the same bacteria (p<0.05); uppercase letters in the inset table represent 
statistically significant differences between bacterial species and the same fiber group 
(p<0.05).
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Fig. 3. 
Representative SEM images of the electrospun fibers following Pg exposure. (A) control 
PLA:PCL/GEL [TCH-free], (B) PLA:PCL/GEL+5wt.%TCH, (C) PLA:PCL/GEL+10wt.
%TCH, and (D) PLA:PCL/GEL+25wt.%TCH. (A) Note the presence of Pg biofilm covering 
most of the nanofibrous surface. Inset SEM image (10,000× magnification, scale bar = 1 
μm) demonstrates the morphological aspects of Pg. (B) SEM image indicates (white circles) 
the presence of Pg bacteria only in a few areas on the 5 wt.% of TCH-containing fibers. (C–
D) SEM images revealing complete absence of Pg on the fibers containing TCH at 10 and 
25 wt.%.
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Fig. 4. 
Representative SEM images of the electrospun fibers following Fn exposure. (A) control 
PLA:PCL/GEL [TCH-free], (B) PLA:PCL/GEL+5wt.%TCH, (C) PLA:PCL/GEL+10wt.
%TCH, and (D) PLA:PCL/GEL+25wt.%TCH. (A) Note the presence of Fn biofilm (solid 
white arrows) covering most of the nanofibrous (dotted white arrow) surface. Upper inset 
SEM image (5,000× magnification, scale bar = 5 μm) indicates the morphological aspects of 
Fn. Lower inset graph demonstrates the mean bacterial diameter. (B) SEM image 
demonstrates (white arrow) the presence of Fn bacteria only in a few areas on the 5 wt.% of 
TCH-containing fibers. (C–D) SEM images revealing complete absence of Fn on the fibers.
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Fig. 5. 
Representative SEM images of the electrospun fibers following Aa exposure. (A) control 
PLA:PCL/GEL [TCH-free], (B) PLA:PCL/GEL+5wt.%TCH, (C) PLA:PCL/GEL+10wt.
%TCH, and (D) PLA:PCL/GEL+25wt.%TCH. (A) Note the presence of Aa biofilm 
covering the nanofibrous surface. Inset SEM image (10,000× magnification, scale bar = 1 
μm) demonstrates the morphological aspects of Aa. (B–D) SEM images revealing complete 
absence of Aa over all TCH-containing fibers.
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Fig. 6. 
Representative SEM images of the electrospun fibers following Pi exposure. (A) control 
PLA:PCL/GEL [TCH-free], (B) PLA:PCL/GEL+5wt.%TCH, (C) PLA:PCL/GEL+10wt.
%TCH, and (D) PLA:PCL/GEL+25wt.%TCH. (A) Note the presence of Pi biofilm (white 
circles) covering most of the nanofibrous surface. Inset SEM image (10,000× magnification, 
scale bar = 1 μm) demonstrates the morphological aspects of Pi. (B–D) SEM images 
revealing a few areas with Pi in all TCH-containing fibers.
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